<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d381" origId="Bisoprolol"><sentence id="DrugDDI.d381.s0" origId="s0" text="ZEBETA should not be combined with other beta-blocking agents."><entity id="DrugDDI.d381.s0.e0" origId="s0.p0" charOffset="0-6" type="drug" text="ZEBETA"/><entity id="DrugDDI.d381.s0.e1" origId="s0.p5" charOffset="41-60" type="drug" text="beta-blocking agent"/><pair id="DrugDDI.d381.s0.p0" e1="DrugDDI.d381.s0.e0" e2="DrugDDI.d381.s0.e1" interaction="true"/></sentence><sentence id="DrugDDI.d381.s1" origId="s1" text="Patients receiving catecholamine-depleting drugs, such as reserpine or guanethidine, should be closely monitored, because the added beta-adrenergic blocking action of ZEBETA may produce excessive reduction of sympathetic activity."><entity id="DrugDDI.d381.s1.e0" origId="s1.p8" charOffset="43-48" type="drug" text="drugs"/><entity id="DrugDDI.d381.s1.e1" origId="s1.p9" charOffset="58-67" type="drug" text="reserpine"/><entity id="DrugDDI.d381.s1.e2" origId="s1.p11" charOffset="71-83" type="drug" text="guanethidine"/><entity id="DrugDDI.d381.s1.e3" origId="s1.p19" charOffset="167-173" type="drug" text="ZEBETA"/><pair id="DrugDDI.d381.s1.p0" e1="DrugDDI.d381.s1.e0" e2="DrugDDI.d381.s1.e1" interaction="false"/><pair id="DrugDDI.d381.s1.p1" e1="DrugDDI.d381.s1.e0" e2="DrugDDI.d381.s1.e2" interaction="false"/><pair id="DrugDDI.d381.s1.p2" e1="DrugDDI.d381.s1.e0" e2="DrugDDI.d381.s1.e3" interaction="true"/><pair id="DrugDDI.d381.s1.p3" e1="DrugDDI.d381.s1.e1" e2="DrugDDI.d381.s1.e2" interaction="false"/><pair id="DrugDDI.d381.s1.p4" e1="DrugDDI.d381.s1.e1" e2="DrugDDI.d381.s1.e3" interaction="true"/><pair id="DrugDDI.d381.s1.p5" e1="DrugDDI.d381.s1.e2" e2="DrugDDI.d381.s1.e3" interaction="true"/></sentence><sentence id="DrugDDI.d381.s2" origId="s2" text="In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that ZEBETA be discontinued for several days before the withdrawal of clonidine."><entity id="DrugDDI.d381.s2.e0" origId="s2.p27" charOffset="46-55" type="drug" text="clonidine"/><entity id="DrugDDI.d381.s2.e1" origId="s2.p38" charOffset="112-118" type="drug" text="ZEBETA"/><entity id="DrugDDI.d381.s2.e2" origId="s2.p43" charOffset="177-186" type="drug" text="clonidine"/><pair id="DrugDDI.d381.s2.p0" e1="DrugDDI.d381.s2.e0" e2="DrugDDI.d381.s2.e1" interaction="false"/><pair id="DrugDDI.d381.s2.p1" e1="DrugDDI.d381.s2.e0" e2="DrugDDI.d381.s2.e2" interaction="false"/><pair id="DrugDDI.d381.s2.p2" e1="DrugDDI.d381.s2.e1" e2="DrugDDI.d381.s2.e2" interaction="true"/></sentence><sentence id="DrugDDI.d381.s3" origId="s3" text="ZEBETA should be used with care when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists (particularly of the phenylalkylamine [verapamil] and benzothiazepine [diltiazem] classes), or antiarrhythmic agents, such as disopyramide, are used concurrently."><entity id="DrugDDI.d381.s3.e0" origId="s3.p44" charOffset="0-6" type="drug" text="ZEBETA"/><entity id="DrugDDI.d381.s3.e1" origId="s3.p50" charOffset="37-59" type="drug" text="myocardial depressants"/><entity id="DrugDDI.d381.s3.e2" origId="s3.p54" charOffset="108-126" type="drug" text="calcium antagonist"/><entity id="DrugDDI.d381.s3.e3" origId="s3.p57" charOffset="167-176" type="drug" text="verapamil"/><entity id="DrugDDI.d381.s3.e4" origId="s3.p59" charOffset="199-208" type="drug" text="diltiazem"/><entity id="DrugDDI.d381.s3.e5" origId="s3.p63" charOffset="223-243" type="drug" text="antiarrhythmic agent"/><entity id="DrugDDI.d381.s3.e6" origId="s3.p64" charOffset="254-266" type="drug" text="disopyramide"/><pair id="DrugDDI.d381.s3.p0" e1="DrugDDI.d381.s3.e0" e2="DrugDDI.d381.s3.e1" interaction="true"/><pair id="DrugDDI.d381.s3.p1" e1="DrugDDI.d381.s3.e0" e2="DrugDDI.d381.s3.e2" interaction="false"/><pair id="DrugDDI.d381.s3.p2" e1="DrugDDI.d381.s3.e0" e2="DrugDDI.d381.s3.e3" interaction="true"/><pair id="DrugDDI.d381.s3.p3" e1="DrugDDI.d381.s3.e0" e2="DrugDDI.d381.s3.e4" interaction="false"/><pair id="DrugDDI.d381.s3.p4" e1="DrugDDI.d381.s3.e0" e2="DrugDDI.d381.s3.e5" interaction="true"/><pair id="DrugDDI.d381.s3.p5" e1="DrugDDI.d381.s3.e0" e2="DrugDDI.d381.s3.e6" interaction="false"/><pair id="DrugDDI.d381.s3.p6" e1="DrugDDI.d381.s3.e1" e2="DrugDDI.d381.s3.e2" interaction="false"/><pair id="DrugDDI.d381.s3.p7" e1="DrugDDI.d381.s3.e1" e2="DrugDDI.d381.s3.e3" interaction="false"/><pair id="DrugDDI.d381.s3.p8" e1="DrugDDI.d381.s3.e1" e2="DrugDDI.d381.s3.e4" interaction="false"/><pair id="DrugDDI.d381.s3.p9" e1="DrugDDI.d381.s3.e1" e2="DrugDDI.d381.s3.e5" interaction="false"/><pair id="DrugDDI.d381.s3.p10" e1="DrugDDI.d381.s3.e1" e2="DrugDDI.d381.s3.e6" interaction="false"/><pair id="DrugDDI.d381.s3.p11" e1="DrugDDI.d381.s3.e2" e2="DrugDDI.d381.s3.e3" interaction="false"/><pair id="DrugDDI.d381.s3.p12" e1="DrugDDI.d381.s3.e2" e2="DrugDDI.d381.s3.e4" interaction="false"/><pair id="DrugDDI.d381.s3.p13" e1="DrugDDI.d381.s3.e2" e2="DrugDDI.d381.s3.e5" interaction="false"/><pair id="DrugDDI.d381.s3.p14" e1="DrugDDI.d381.s3.e2" e2="DrugDDI.d381.s3.e6" interaction="false"/><pair id="DrugDDI.d381.s3.p15" e1="DrugDDI.d381.s3.e3" e2="DrugDDI.d381.s3.e4" interaction="false"/><pair id="DrugDDI.d381.s3.p16" e1="DrugDDI.d381.s3.e3" e2="DrugDDI.d381.s3.e5" interaction="false"/><pair id="DrugDDI.d381.s3.p17" e1="DrugDDI.d381.s3.e3" e2="DrugDDI.d381.s3.e6" interaction="false"/><pair id="DrugDDI.d381.s3.p18" e1="DrugDDI.d381.s3.e4" e2="DrugDDI.d381.s3.e5" interaction="false"/><pair id="DrugDDI.d381.s3.p19" e1="DrugDDI.d381.s3.e4" e2="DrugDDI.d381.s3.e6" interaction="false"/><pair id="DrugDDI.d381.s3.p20" e1="DrugDDI.d381.s3.e5" e2="DrugDDI.d381.s3.e6" interaction="false"/></sentence><sentence id="DrugDDI.d381.s4" origId="s4" text="Concurrent use of rifampin increases the metabolic clearance of ZEBETA, resulting in a shortened elimination half-life of ZEBETA."><entity id="DrugDDI.d381.s4.e0" origId="s4.p69" charOffset="18-26" type="drug" text="rifampin"/><entity id="DrugDDI.d381.s4.e1" origId="s4.p72" charOffset="64-70" type="drug" text="ZEBETA"/><entity id="DrugDDI.d381.s4.e2" origId="s4.p75" charOffset="122-128" type="drug" text="ZEBETA"/><pair id="DrugDDI.d381.s4.p0" e1="DrugDDI.d381.s4.e0" e2="DrugDDI.d381.s4.e1" interaction="true"/><pair id="DrugDDI.d381.s4.p1" e1="DrugDDI.d381.s4.e0" e2="DrugDDI.d381.s4.e2" interaction="false"/><pair id="DrugDDI.d381.s4.p2" e1="DrugDDI.d381.s4.e1" e2="DrugDDI.d381.s4.e2" interaction="false"/></sentence><sentence id="DrugDDI.d381.s5" origId="s5" text="However, initial dose modification is generally not necessary."/><sentence id="DrugDDI.d381.s6" origId="s6" text="Pharmacokinetic studies document no clinically relevant interactions with other agents given concomitantly, including thiazide diuretics, digoxin, and cimetidine."><entity id="DrugDDI.d381.s6.e0" origId="s6.p88" charOffset="118-136" type="drug" text="thiazide diuretics"/><entity id="DrugDDI.d381.s6.e1" origId="s6.p89" charOffset="138-145" type="drug" text="digoxin"/><entity id="DrugDDI.d381.s6.e2" origId="s6.p91" charOffset="151-161" type="drug" text="cimetidine"/><pair id="DrugDDI.d381.s6.p0" e1="DrugDDI.d381.s6.e0" e2="DrugDDI.d381.s6.e1" interaction="false"/><pair id="DrugDDI.d381.s6.p1" e1="DrugDDI.d381.s6.e0" e2="DrugDDI.d381.s6.e2" interaction="false"/><pair id="DrugDDI.d381.s6.p2" e1="DrugDDI.d381.s6.e1" e2="DrugDDI.d381.s6.e2" interaction="false"/></sentence><sentence id="DrugDDI.d381.s7" origId="s7" text="There was no effect of ZEBETA on prothrombin time in patients on stable doses of warfarin."><entity id="DrugDDI.d381.s7.e0" origId="s7.p95" charOffset="23-29" type="drug" text="ZEBETA"/><entity id="DrugDDI.d381.s7.e1" origId="s7.p99" charOffset="81-89" type="drug" text="warfarin"/><pair id="DrugDDI.d381.s7.p0" e1="DrugDDI.d381.s7.e0" e2="DrugDDI.d381.s7.e1" interaction="false"/></sentence><sentence id="DrugDDI.d381.s8" origId="s8" text="Risk of Anaphylactic Reaction: While taking beta-blockers, patients with a history of severe anaphylactic reaction to a variety of allergens may be more reactive to repeated challenge, either accidental, diagnostic, or therapeutic."><entity id="DrugDDI.d381.s8.e0" origId="s8.p104" charOffset="44-58" type="drug" text="beta-blockers"/></sentence><sentence id="DrugDDI.d381.s9" origId="s9" text="Such patients may be unresponsive to the usual doses of epinephrine used to treat allergic reactions."><entity id="DrugDDI.d381.s9.e0" origId="s9.p123" charOffset="56-67" type="drug" text="epinephrine"/></sentence></document>